Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?

Polymyalgia rheumatica (PMR) and giant-cell arteritis (GCA) with symptoms of PMR share some pathophysiologic features. Interleukin 6 (IL-6) levels are elevated in both groups. We investigated the effect of tocilizumab (TCZ), an IL-6 inhibitor, in both populations and whether there were any differenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Farinango, Michelle, Ansary, Akhil, Dakka, Amulya, Nazir, Zahra, Shamim, Humaira, Jean, Marie, Umair, Muaaz, Muddaloor, Pratyusha, Chavarria, Yeny, Khan, Safeera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9435397/
https://www.ncbi.nlm.nih.gov/pubmed/36059312
http://dx.doi.org/10.7759/cureus.27606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9435397/
https://www.ncbi.nlm.nih.gov/pubmed/36059312
http://dx.doi.org/10.7759/cureus.27606

Ejemplares similares